184 related articles for article (PubMed ID: 21466481)
1. Stem cells in brain tumorigenesis and their impact on therapy.
Cardona AF; Balañá C; Torres D; Becerra H; Ortíz LD; Fadul CE
Curr Stem Cell Res Ther; 2011 Dec; 6(4):339-49. PubMed ID: 21466481
[TBL] [Abstract][Full Text] [Related]
2. Brain tumour stem cells.
Vescovi AL; Galli R; Reynolds BA
Nat Rev Cancer; 2006 Jun; 6(6):425-36. PubMed ID: 16723989
[TBL] [Abstract][Full Text] [Related]
3. Biology of glioma cancer stem cells.
Park DM; Rich JN
Mol Cells; 2009 Jul; 28(1):7-12. PubMed ID: 19655094
[TBL] [Abstract][Full Text] [Related]
4. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.
Park HJ; Kim JK; Jeon HM; Oh SY; Kim SH; Nam DH; Kim H
Mol Cells; 2010 Nov; 30(5):403-8. PubMed ID: 20814749
[TBL] [Abstract][Full Text] [Related]
5. Targeting brain-tumor stem cells.
Stupp R; Hegi ME
Nat Biotechnol; 2007 Feb; 25(2):193-4. PubMed ID: 17287755
[No Abstract] [Full Text] [Related]
6. The pathological characteristics of glioma stem cell niches.
He H; Li MW; Niu CS
J Clin Neurosci; 2012 Jan; 19(1):121-7. PubMed ID: 22178090
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
8. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glioma stem-like cells from human glioblastomas.
Yamamuro S; Okamoto Y; Sano E; Ochiai Y; Ogino A; Ohta T; Hara H; Ueda T; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Jul; 47(1):91-6. PubMed ID: 25955568
[TBL] [Abstract][Full Text] [Related]
10. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.
Swartling FJ; Savov V; Persson AI; Chen J; Hackett CS; Northcott PA; Grimmer MR; Lau J; Chesler L; Perry A; Phillips JJ; Taylor MD; Weiss WA
Cancer Cell; 2012 May; 21(5):601-613. PubMed ID: 22624711
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cells and the biology of brain tumors.
Flores DG; Ledur PF; Abujamra AL; Brunetto AL; Schwartsmann G; Lenz G; Roesler R
Curr Stem Cell Res Ther; 2009 Dec; 4(4):306-13. PubMed ID: 19804368
[TBL] [Abstract][Full Text] [Related]
12. CXCR4-positive subset of glioma is enriched for cancer stem cells.
Zheng X; Xie Q; Li S; Zhang W
Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188
[TBL] [Abstract][Full Text] [Related]
13. The cyclin-like protein Spy1 regulates growth and division characteristics of the CD133+ population in human glioma.
Lubanska D; Market-Velker BA; deCarvalho AC; Mikkelsen T; Fidalgo da Silva E; Porter LA
Cancer Cell; 2014 Jan; 25(1):64-76. PubMed ID: 24434210
[TBL] [Abstract][Full Text] [Related]
14. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis.
Kusne Y; Sanai N
Adv Exp Med Biol; 2015; 853():23-32. PubMed ID: 25895705
[TBL] [Abstract][Full Text] [Related]
15. Stem cell markers in gliomas.
Dell'Albani P
Neurochem Res; 2008 Dec; 33(12):2407-15. PubMed ID: 18493853
[TBL] [Abstract][Full Text] [Related]
16. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
17. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
[TBL] [Abstract][Full Text] [Related]
19. Glioma stem cell signaling: therapeutic opportunities and challenges.
Dietrich J; Diamond EL; Kesari S
Expert Rev Anticancer Ther; 2010 May; 10(5):709-22. PubMed ID: 20470003
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in the central nervous system--a critical review.
Prestegarden L; Enger PØ
Cancer Res; 2010 Nov; 70(21):8255-8. PubMed ID: 20959482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]